The Centers for Medicare & Medicaid Services (CMS) notified Medicare Advantage organizations and Part D Plans that it will conduct reassignment this month of beneficiaries eligible for the Part D Low-Income Subsidy (LIS) who are enrolled in certain MA plans and MA-PD plans. These include plans reducing their service area or plans that have a Part D premium above a certain threshold. Beneficiaries must be eligible for LIS for 2023 and remain eligible for 2024. CMS will conduct all reassignments, including assigning beneficiaries into zero premium Prescription Drug Plans (PDP) owned by the same organization, if available, or randomly assigning beneficiaries to PDPs offered by different sponsors.
CMS will notify affected beneficiaries by mail. CMS will mail the first of two notices, printed on blue paper, to affected beneficiaries in mid-November. This notice will inform beneficiaries who are being reassigned of their prospective zero premium PDP and indicate that they will have Original Medicare as their health coverage unless they choose another MA plan. CMS will mail the second blue notice in late-November. The second notice will identify which drugs in their current drug regimen are on the formulary of the 2024 plan to which they are being reassigned, and how to request an exception or appeal, or file a grievance. Once these notices are finalized, they will be available at LIS Notices and Mailings | CMS.
For more information, see:
- Medicare Prescription Drug Eligibility and Enrollment | CMS
- Notice from CMS: 2024 Reassignment of Low-Income Subsidy Beneficiaries in Non-Renewing Medicare Advantage Plans and Medicare Advantage Plans Reducing their Service Areas
- Notice from CMS: 2024 Reassignment of Low-Income Subsidy Beneficiaries in Prescription Drug Plans
October 5, 2023 – K. Kertesz